Fig. 2.

Sclerostin inhibits osteoblast proliferation and differentiation in both the early and late stages, limiting bone formation. Sclerostin also promotes osteoblast apoptosis and RANKL release, both of which are necessary for osteoclast activity and differentiation.²⁶-²⁹)